1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Ear Care in the US

Ear Care in the US

  • April 2013
  • -
  • Euromonitor International
  • -
  • 34 pages

Summary

Table of Contents

Search Inside

The sale of Debrox to Prestige Brands marked GlaxoSmithKline’s departure from ear care in the US. Given that GlaxoSmithKline formerly led sales, the move represented a strategic shake-up in a category that witnessed very little development over the review period. The acquisition gives Prestige a majority share of ear care, placing it in a strong competitive position against both private label and smaller branded competitors.

Euromonitor International's Ear Care in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Ear Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Receive information concerning the dynamics and forecasts in the OTC drugs and dietary supplements market - Receive information pertaining to the major regional trends in the global ...

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Opportunity in the Indian OTC Drug Market - 2017

Opportunity in the Indian OTC Drug Market - 2017

  • $ 4500
  • Industry report
  • March 2017
  • by Feedback Business Consulting

This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: - Current market size estimate - Revenues by players - Top 5 Companies - Market ...

Otc Drugs Markets In China

January 2017 $ 4000

The Bric Otc Market To 2025

April 2017 $ 2199

Otc Drugs Companies In China

January 2017 $ 1800

Download Unlimited Documents from Trusted Public Sources

OTC Industry in China

  • April 2017
    12 pages
  • Vitamin  

  • China  

View report >

OTC Markets in Europe - Forecast

  • April 2017
    3 pages
  • Healthcare  

    Vitamin  

    Mineral Supplem...  

  • Europe  

    Belgium  

View report >

Pharmaceutical Sales Demand

  • April 2017
    4 pages
  • Pharmaceutical  

  • Germany  

    Europe  

    Poland  

View report >

Global Otc Markets

25 days ago

Otc Markets In The Us

1 month ago

Otc Supply In The Us

2 months ago

Related Market Segments :

OTC
Dietary Supplement
Vitamin

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.